Cambridge Innovation Capital
Cambridge, Englandcic.vc
Overview
Cambridge Innovation Capital (CIC) is a leading venture capital investor backing and building category-leading deep tech and life sciences companies . The firm invests in early-stage companies, particularly those based in or close to the Cambridge ecosystem or with links to the University of Cambridge . CIC focuses on artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech, diagnostics, digital health, and genomics and proteomics .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRIMTECH Therapeutics | Jun 2026 | Seed | Co-investor |
| Trent AI | Apr 2026 | Seed | Lead |
| Immutrin | Mar 2026 | Series A | Co-investor |
| BeyondMath | Feb 2026 | Seed | Lead |
| Nuclera | Jan 2026 | Series C Extension | Co-investor |
Key People
Andrew Williamson
Managing Partner
Ian Jauncey
Operating Partner
Paul Anson
Operating Partner
Robert Tansley
Venture Partner
Anne Horgan
Partner
Ian Lane
Partner
Michael Anstey
Partner
Rob Sprawson
Partner CFO
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
